Synapse to Society: Addiction Medicine State of the Art 2015
The speed of change in the field of Addiction Medicine is accelerating. From healthcare reform to marijuana legalization and from drug trading on “the hidden web” to pharmacogenetics, in the 2015 CSAM State of the Art conference provides tools to help you navigate this brave new world. Another focus of the conference is the fast changing landscape of pain and addiction with speakers, including Anna Lembke, MD, Andrea Rubinstein, MD, and Jodie Trafton, PhD. The conference brings you the topics most relevant to your practice, as well as topics you may soon find landing on your doorstep.
The conference explores synapses, both inside the brain and outside in technology, beginning with NIAAA director, George Koob, PhD, updating clinicians on the research pipeline, and ending with a presentation on naltrexone pharmacogenetics. The conference covers the emerging area of the impact of the internet on drug use and delivery of addiction treatment including how computer science can be used to aid our field. It will explore the new world of deep brain stimulation. On the societal level, we cover topics ranging from the Affordable Care Act with H. Westley Clark, MD, JD, MPH reviewing lessons learned so far, to public health lessons learned from Colorado’s experience with legalization of marijuana. We will also explore food addiction with Eric Zorilla, PhD and offer a glimpse into integrative medicine with Sharone Abramowitz, MD.
Recorded October 21-24, 2015.
PRICE/PURCHASE -- $500
You must sign in or register register on this site before purchasing using the link on the upper right corner of this page. Only after registering will you see the "Add to Cart" button. To purchase, scroll to the bottom of the page and click "Add to Cart."
PHYSICIANS: The California Society of Addiction Medicine (CSAM) is accredited by the Institute for Medical Quality/California Medical Association to provide continuing medical education for physicians. CSAM takes responsibility for the content, quality and scientific integrity of this CME activity.
CSAM designates this live educational activity for a maximum of 16.5 AMA PRA Category 1 Credit™ Physicians should only claim credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA Certification in Continuing Medical Education.
This course has been approved by the American Board of Addiction Medicine (ABAM) for MOC credit. Physicians enrolled in the ABAM Maintenance of Certification (MOC) Program can apply a maximum of 16.5 AMA/PRA Category 1 Credit™ for completing the Review Course.
Continuing education credit is also available for nurses, psychologists, pharmacists, physician assistants, therapists, and drug abuse counselors.
- Addiction medicine specialists who want an overview of the latest developments in the field and their relevance to clinical practice
- Primary care clinicians who want to get a better understanding of addiction and manage patients with addictions in their practice
- Public health officials who want an understanding of the current state of addiction treatment
- Non-physicians who are involved in the treatment of addiction
At the end of this activity attendees should be able to (partial list):
- Utilize new web-based technologies in their addiction medicine practice
- Apply research into gender differences to improve the treatment of addiction in women patients
- Employ integrative medicine with patients;
- Develop strategies to treat patients with chronic pain while preventing addiction and diversion
- Make practice changes to improve treatment under the Affordable Care Act
- Discuss the advantages of new medications for HCV
Educational objectives for each lecture/module are available on its course page.
- 16.50 AMA Category 1